What does Rani Therapeutics Holdings, Inc. do?
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill…
What is Rani Therapeutics Holdings, Inc.'s P/E and P/B ratio?
Rani Therapeutics Holdings, Inc. has a P/E ratio of -3.9 and a P/B ratio of 2.10.
What is Rani Therapeutics Holdings, Inc.'s debt-to-equity ratio?
Rani Therapeutics Holdings, Inc. has a debt-to-equity ratio of 0.07.
How much does Rani Therapeutics Holdings, Inc. owe compared with what it owns?
Rani Therapeutics Holdings, Inc. owes $0.21 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Rani Therapeutics Holdings, Inc.'s Positivity rank?
Rani Therapeutics Holdings, Inc. is ranked #3,856 of 6,774 companies globally and #1,783 of 4,000 in United States on PositoAI, with a Positivity Score of 20,149.
Does Rani Therapeutics Holdings, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Rani Therapeutics Holdings, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 15 May 2026). It has no yellow flags.
Where can I read the latest news about Rani Therapeutics Holdings, Inc.?
Recent headlines about Rani Therapeutics Holdings, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Rani Therapeutics Holdings, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Rani Therapeutics Holdings, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.